Podcast

Cherise Rohr-Allegrini, PhD, MPH, on Vaccine-Preventable Outbreaks

05/24/2019

 

Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks.

Cherise Rohr-Allegrini, PhD, MPH, is the San Antonio Program Director at The Immunization Partnership in San Antonio, Texas.

 

References:

  1. The Immunization Partnership. https://www.immunizeusa.org. Updated 2019.
  2. Vaccine ingredients. Children's Hospital of Philadelphia. https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-ingredients. Updated January 08, 2019.
  3. Vaccine Education Center. Children's Hospital of Philadelphia. https://www.chop.edu/centers-programs/vaccine-education-center. Updated 2019.

 

Published in partnership with Texas Biomedical Research Institute

Related Content

Esophageal Disorders
Esophageal Disorders
Dhyanesh A. Patel, MD, on PPI Use and Risk of Adverse Effects
01/09/2020
Dr Patel, from Vanderbilt University Medical Center, highlights the current role of proton-pump inhibitors and related adverse effects, indications for their use, and more.
01/09/2020
Stress and Burnout
Stress and Burnout
Bruce Y. Lee, MD, on the FDA’s Emergency Authorization of Remdesivir
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Infectious Diseases
Infectious Diseases
Shane Crotty, PhD, on the Tfh Pathway
12/09/2018
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
12/09/2018
Cardiovascular Diseases
Cardiovascular Diseases
Expert Conversations: How to Choose and Initiate a Novel Agent for Patients With CVD and Diabetes
04/21/2020
In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about treating patients with cardiovascular disease and diabetes—with a special focus on how to choose the appropriate novel...
04/21/2020
Multiple Sclerosis
Multiple Sclerosis
Abbey Hughes, MD, on Using the GAD-2 for Screening Anxiety in Patients With MS
11/06/2018
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
11/06/2018